Please login to the form below

Not currently logged in
Email:
Password:

Evan Lippman joins Aileron Therapeutics

He has experience at EMD Serono, Pfizer and AstraZeneca
Evan Lippman joins Aileron Therapeutics

Aileron Therapeutics has added to its senior team with the appointment of Evan Lippman as its first chief financial and business officer.

The addition comes as the US biopharma prepares to advance its lead oncology candidate ALRN-6924 into clinical trials.

In Lippman Aileron gains the expertise of a man with great experience in life sciences. Most recently Lippman help a senior VP role at EMD Serono heading the strategy for its US neurology franchise.

Highlights of his career include a spell as executive director at AstraZeneca where he led on huge brands such as Crestor (rosuvastatin calcium) and Nexium (esomeprazole) and heading US business development at the same company.

Lippman's other big pahrma experience includes a period at Pfizer as executive director, worldwide business development and strategic planning.

12th January 2015

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Can you survive without the blue dot?
Or has the digital world has replaced our brain...
Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...

Infographics